NYSE / NASDAQ · SEC EDGAR

Equity research

Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.

Research preview · Quarterly financial statements · No price quotes · Not financial advice

7669Listed tickers in the SEC universe 1972Issuers with current reporting periods 451Issuers with both EPS and ROE metrics 2026-09-20Fundamentals evaluated as of

Example screens

Example lists from a senior trader

Reset filters

All selected filters are combined. Paste up to 100 tickers to intersect your own list with the results. A missing metric does not pass a numeric filter.

1972 companies match

Showing 601–650 of 1972 · page 13/40

Per page 2550100
CompanyCombined rankEPS accelerationRevenue growthROENet margin Reporting period
AIROAIRO Group Holdings, Inc.NASDAQ 75.9% 2026-06-30Filed 2026-08-13
AIRSAirsculpt Technologies, Inc.NASDAQ -2.5% 2026-06-30Filed 2026-08-10
AIRTAIR T INCNASDAQ 62.9% 2026-06-30Filed 2026-08-14
AISPAirship AI Holdings, Inc.NASDAQ 92.1% 2026-06-30Filed 2026-08-06
AITAPPLIED INDUSTRIAL TECHNOLOGIES INCNYSE -1.9 pp 7.3% 2026-06-30Filed 2026-08-13
AIXCAIxCrypto Holdings, Inc.NASDAQ 2026-06-30Filed 2026-08-07
AIZASSURANT, INC.NYSE -60.7 pp 9.4% 2026-06-30Filed 2026-08-06
AJGArthur J. Gallagher & Co.NYSE -26.9 pp 24.2% 2026-06-30Filed 2026-08-05
AKAA.K.A. BRANDS HOLDING CORP.NYSE -0.3% 2026-06-30Filed 2026-08-05
AKAMAKAMAI TECHNOLOGIES INCNASDAQ -13.3 pp 2026-06-30Filed 2026-08-07
AKBAAkebia Therapeutics, Inc.NASDAQ -21.4% 2026-06-30Filed 2026-08-05
AKRACADIA REALTY TRUSTNYSE -1700.0 pp -5.1% 2026-06-30Filed 2026-07-29
AKTSAktis Oncology, Inc.NASDAQ 111.4% 2026-06-30Filed 2026-08-13
AKTXAkari Therapeutics PlcNASDAQ 2026-06-30Filed 2026-08-13
ALABAstera Labs, Inc.NASDAQ 41.8 pp 104.5% 2026-06-30Filed 2026-08-05
ALBALBEMARLE CORPNYSE 31.1% 2026-06-30Filed 2026-08-05
ALCOALICO, INC.NASDAQ 7.7% 2026-06-30Filed 2026-08-10
ALDFAldel Financial II Inc.NASDAQ 2026-06-30Filed 2026-07-21
ALDXAldeyra Therapeutics, Inc.NASDAQ 2026-06-30Filed 2026-08-06
ALECAlector, Inc.NASDAQ -57.8% 2026-06-30Filed 2026-08-06
ALFCenturion Acquisition Corp.NASDAQ 2026-06-30Filed 2026-08-14
ALGALAMO GROUP INCNYSE 7.9 pp 7.6% 2026-06-30Filed 2026-08-03
ALGMALLEGRO MICROSYSTEMS, INC.NASDAQ 27.5% 2026-06-26Filed 2026-07-31
ALGNALIGN TECHNOLOGY INCNASDAQ -35.8 pp 4.3% 2026-06-30Filed 2026-08-05
ALGSAligos Therapeutics, Inc.NASDAQ -100.0% 2026-06-30Filed 2026-08-06
ALGTAllegiant Travel CONASDAQ 33.1% 2026-06-30Filed 2026-08-10
ALHAlliance Laundry Holdings Inc.NYSE -91.1 pp 6.6% 2026-06-30Filed 2026-08-13
ALHCAlignment Healthcare, Inc.NASDAQ 31.6% 2026-06-30Filed 2026-07-30
ALISCalisa Acquisition CorpNASDAQ 2026-06-30Filed 2026-08-07
ALITAlight, Inc. / DelawareNYSE -3.2% 2026-06-30Filed 2026-08-04
ALKALASKA AIR GROUP, INC.NYSE 9.7% 2026-06-30Filed 2026-08-04
ALKSAlkermes plc.NASDAQ 307.7 pp 27.0% 2026-06-30Filed 2026-07-28
ALKTALKAMI TECHNOLOGY, INC.NASDAQ 15.9% 2026-06-30Filed 2026-07-30
ALLALLSTATE CORPNYSE -277.2 pp 11.8% 2026-06-30Filed 2026-08-05
ALLEAllegion plcNYSE 23.2 pp 12.7% 2026-06-30Filed 2026-07-23
ALLOAllogene Therapeutics, Inc.NASDAQ 2026-06-30Filed 2026-08-12
ALLRAllarity Therapeutics, Inc.NASDAQ 2026-06-30Filed 2026-08-14
ALLYAlly Financial Inc.NYSE -0.6% 2026-06-30Filed 2026-07-23
ALMRAlamar Biosciences, Inc.NASDAQ 82.1% 2026-06-30Filed 2026-08-11
ALMSALUMIS INC.NASDAQ -37.7% 2026-06-30Filed 2026-08-13
ALMUAeluma, Inc.NASDAQ -2.6% 2026-03-31Filed 2026-05-13
ALNTALLIENT INCNASDAQ 27.0 pp 10.2% 2026-06-30Filed 2026-08-05
ALNYALNYLAM PHARMACEUTICALS, INC.NASDAQ 66.9% 2026-06-30Filed 2026-07-30
ALOVAldabra 4 Liquidity Opportunity Vehicle, Inc.NASDAQ 2026-06-30Filed 2026-08-14
ALOYREALLOYS INC.NASDAQ 82.7% 2026-06-30Filed 2026-08-13
ALPXAlpex Acquisition CorpNASDAQ 2026-06-30Filed 2026-08-13
ALRMAlarm.com Holdings, Inc.NASDAQ -14.2 pp 9.2% 2026-06-30Filed 2026-08-06
ALRSALERUS FINANCIAL CORPNASDAQ -67.3 pp 2026-06-30Filed 2026-08-03
ALSNAllison Transmission Holdings IncNYSE 34.2 pp 92.4% 2026-06-30Filed 2026-08-05
ALTAltimmune, Inc.NASDAQ 2026-06-30Filed 2026-08-12

How the lists overlap

EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.

The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.

Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.

What this data covers

Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.

The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.

Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.

Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-09-18. Source: FRED / Federal Reserve.